Targeting PML-RARαand Oncogenic Signaling Pathways by Chinese Herbal MixtureTien-HsienLiquid in Acute Promyelocytic Leukemia NB4 Cells

Author:

Yao Chih-Jung1,Yang Chia-Ming2,Chuang Shuang-En3,Yan Jiann-Long3,Liu Chun-Yen2,Chen Suz-Wen3,Yan Kun-Huang34,Lai Tung-Yuan56,Lai Gi-Ming13

Affiliation:

1. Cancer Center, Taipei Medical University-Wan Fang Hospital, Taiwan

2. Formosa Cancer Foundation, Taipei, Taiwan

3. National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan

4. Department of Life Science, National Tsing Hua University, Hsinchu, Taiwan

5. School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan

6. Department of Chinese Internal Medicine, China Medical University Hospital, Taichung, Taiwan

Abstract

Tien-HsienLiquid (THL) is a Chinese herbal mixture that has been used worldwide as complementary treatment for cancer patients in the past decade. Recently, THL has been shown to induce apoptosis in various types of solid tumor cellsin vitro. However, the underlying molecular mechanisms have not yet been well elucidated. In this study, we explored the effects of THL on acute promyelocytic leukemia (APL) NB4 cells, which could be effectively treated by some traditional Chinese remedies containing arsenic trioxide. The results showed THL could induce G2/M arrest and apoptosis in NB4 cells. Accordingly, the decrease of cyclin A and B1 were observed in THL-treated cells. The THL-induced apoptosis was accompanied with caspase-3 activation and decrease of PML-RARαfusion protein. Moreover, DNA methyltransferase 1 and oncogenic signaling pathways such as Akt/mTOR, Stat3 and ERK were also down-regulated by THL. By using ethyl acetate extraction and silica gel chromatography, an active fraction of THL named as EAS5 was isolated. At about 0.5–1% of the dose of THL, EAS5 appeared to have most of THL-induced multiple molecular targeting effects in NB4 cells. Based on the findings of these multi-targeting effects, THL might be regarding as a complementary and alternative therapeutic agent for refractory APL.

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3